Searched for
PHARMACEUTICAL LITIGATION
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- Zydus Lifesciences to pursue acquisitions in specialty, rare diseasesZydus Lifesciences is set to acquire US firm Assertio Holdings for $166.40 million. This move aims to build a strong specialty oncology bus...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Indian pharma firms likely to see muted revenue growth from US generics market in FY23: IcraOn the outlook, Icra vice president and co-group head Kinjal Shah said, "Icra expects mid to high single-digit price erosion to continue to...
- Sun Pharma arm settles case with Biofrontera, to get USD 22.5 mnIn 2018, DUSA Pharmaceuticals had filed a suit at the US District Court of Massachusetts against Biofrontera Inc Biofrontera Bioscience Gmb...
- Sun Pharma's 2 US arms to pay USD 85 mn in settlement pacts over antritrust litigationUnder the terms of the settlement agreements, the subsidiaries will make an aggregate payment amounting to a combined total of USD 85 milli...
- Alembic Pharmaceuticals gets USFDA's tentative approval for type 2 diabetes drugThe tentatively approved abbreviated new drug application (ANDA) is therapeutically equivalent to the reference listed drug product Glyxamb...
- Alembic Pharma gets tentative USFDA nod for ophthalmic solutionAlembic said it is currently in litigation with Allergan in District Court of New Jersey and the launch of this product will depend on the ...
- Sun Pharma enters settlement in antitrust litigation in US"Sun Pharmaceutical Industries Ltd, and one of its wholly-owned subsidiaries have entered into settlements with certain plaintiffs in re Mo...
- Cadila inks pact with Supernus Pharma to settle patent issueCadila Healthcare have finalised an agreement with Supernus Pharmaceuticals Inc to settle all outstanding patent litigation.
- Cadila Healthcare settles patent litigation related to Livalo tabletsThe company and its subsidiary have finalised an agreement with Kowa Company and Nissan Chemical Industries to settle all outstanding paten...
- Glenmark Pharmaceuticals settles patent litigation over anti-depressant drugGlenmark Pharmaceuticals announced a patent litigation settlement with Forest Laboratories and Royalty Pharma Collection Trust over anti-de...
- Cadila Healthcare, Zydus Pharmaceuticals to settle patent infringement case with Depomed IncThe settlement will allow Cadila and Zydus to begin sell of generic versions of Gralise on January 1, 2024, or earlier under certain circum...
- Intas settles patent litigation with Hoffmann-La Roche for capecitabine tabletAhmedabad-based drug maker, Intas Pharmaceuticals Ltd and its US-based wholly owned subsidiary Accord Healthcare Inc. has entered into a se...
- Glenmark settles patent case with Janssen for generic tabletsGlenmark Pharmaceuticals today said it has settled litigation with Janssen Pharmaceuticals Inc over patent actions regarding generic oral c...
- Settlement of Somaxon Pharmaceuticals patent suit in US soon: ZydusAhmedabad-based Zydus Cadila says, it agreed to settle a patent litigation suit with US-based Somaxon Pharmaceuticals for insomnia drug – S...
- Lupin settles litigation over Lunesta with Japanese firmDrug firm Lupin on Monday said it has settled ongoing litigation over Lunesta tablets, used in treating insomnia, with Japan-based Dainippo...
- Glenmark takes patent cover with drug dealGlenmark Pharmaceuticals issued exclusive marketing rights for cholesterol control ezetimibe to another generic company Par Pharmaceutical ...
- Ranbaxy settles drug dispute with Takeda, US launch in 2012Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the...
- Sun's Caraco settles litigation with Forest Lab in USThe Rs 4,300-crore Sun Pharmaceuticals Ltd's US-subsidiary, Caraco Pharmaceuticals Laboratories Ltd, has gone for settlement of the legal p...
Load More
